Moderna Inc (MRNA)

Total asset turnover

		Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020	Dec 31, 2019	Sep 30, 2019	Jun 30, 2019	Mar 31, 2019
Revenue (ttm)	US$ in thousands	6,758,000	9,088,000	10,654,000	15,059,000	19,263,000	21,390,000	22,995,000	22,600,000	18,471,000	11,831,000	7,019,000	2,732,000	803,000	246,055	106,101	52,184	60,209	81,575
Total assets	US$ in thousands	18,426,000	19,450,000	21,884,000	24,125,000	25,858,000	26,056,000	26,043,000	27,609,000	24,669,000	20,923,000	16,153,000	12,694,000	7,337,000	4,650,870	3,486,010	2,067,540	1,589,420	1,590,900	1,685,280	1,806,210
Total asset turnover		0.37	0.47	0.49	0.62	0.74	0.82	0.88	0.82	0.75	0.57	0.43	0.22	0.11	0.05	0.03	0.03	0.04	0.05

December 31, 2023 calculation

Total asset turnover = Revenue (ttm) ÷ Total assets
= $6,758,000K ÷ $18,426,000K
= 0.37

The total asset turnover for Moderna Inc has shown a declining trend over the past eight quarters, decreasing from 0.74 in Q4 2022 to 0.37 in Q4 2023. This indicates that Moderna Inc is generating less revenue relative to its total assets.

A total asset turnover of less than 1 typically suggests that the company is not efficiently utilizing its assets to generate sales. In this case, the decreasing trend in the total asset turnover may signal inefficiencies in the company's operations or a decline in sales relative to its asset base.

It is important for Moderna Inc to closely monitor and address this trend to improve its operational efficiency and profitability. By identifying the factors contributing to the decline in total asset turnover, the company can implement strategies to optimize its asset utilization and enhance its financial performance.